Akèy › Rabdomiyosakòm › Texas › Dallas
Etid klinik pou Rabdomiyosakòm nan Dallas, TX
3 etid pou Rabdomiyosakòm ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Ap rekriteFaz 1/2
- Children's Medical Center, Dallas
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Ap rekriteFaz 3
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Ap rekriteFaz 1/2
- The University of Texas Southwestern Medical Center, Dallas
Etid Rabdomiyosakòm nan lòt vil
- Houston, TX6 etid
- Memphis, TN6 etid
- Washington, DC5 etid
- Salt Lake City, UT4 etid
- Boston, MA4 etid
- Philadelphia, PA4 etid
- Seattle, WA3 etid
- Aurora, CO3 etid
- Birmingham, AL3 etid
- The Bronx, NY3 etid
- Baltimore, MD3 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Kansè Metastatik42 etid
- Ensifizyans kadyak42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite30 etid
- Kansè ovè28 etid
- Kansè vejik27 etid
- Kansè poumon27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.